Drug Database
Back to search

Netherlands· NL-244b61854626

Fraxiparine 2.850 IE/ 0,3 ml oplossing voor injectie

A nadroparin product containing nadroparine calcium, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC B01AB06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFraxiparine 2.850 IE/ 0,3 ml oplossin…ATCB01AB06REGISTER NO.NL-244b61854626PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nadroparine calciumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nadroparin is registered in 8 of 19 countries.

Countries holding a registration under ATC B01AB06 (nadroparin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search nadroparin products by name

Nadroparin · ATC B01AB06

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NADROPARINE CALCIUM
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
B01AB06
ATC class
Nadroparin
Defined daily dose
2.85 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    136006//11876

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nadroparin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nadroparin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8c1ff97f-4c84-4896-8b61-020d96d3b553
GET /v1/drugs/8c1ff97f-4c84-4896-8b61-020d96d3b553?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11876_smpc.pdf",
  "strength": null,
  "atc_label": "Nadroparin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg136006",
  "excipients": [
    "CALCIUMHYDROXIDE (E 526)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "NADROPARINE CALCIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h136006.pdf",
  "authorised_at": "2025/12/23",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "136006//11876",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nadroparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console